FAIRFIELD, Iowa, December 19, 2013 — Hedge funds gained 0.71% in November, according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index is up 9.84% year to date.
“A rate cut in Europe, far-reaching reforms announced in China, and generally positive economic data contributed to a third month of rising equity prices," says Sol Waksman, founder and president of BarclayHedge.
Sixteen of Barclay’s 18 hedge fund indices had gains in November. The Barclay Healthcare & Biotechnology Index jumped 3.05%, Distressed Securities gained 1.71%, Global Macro added 1.68%, Equity Long Bias was up 1.55%, European Equities gained 1.37%, and Pacific Rim Equities were up 1.24%.
“In spite of a dismal launch that raised concerns about Obamacare’s longer term success, healthcare was the top performing sector in November as well as year to date," says Waksman.
The Healthcare & Biotechnology Index has gained 25.66% in 2013, Pacific Rim Equities are up 20.63%, Equity Long Bias Index has returned 19.23%, Distressed Securities have gained 15.89%, and Equity Long/Short is up 12.10%.
On the losing side, the Equity Short Bias Index was down 2.01% in November, and Emerging Markets lost 0.53%.
The Equity Short Bias Index is now down 25.32% in 2013, surpassing last year’s record loss of 24.12%. All other hedge fund strategies tracked by BarclayHedge have gains year to date.
The Barclay Fund of Funds Index gained 1.01% in November, and is up 7.22% after 11 months in 2013.
Click here to view five years of Barclay Hedge Fund Index data or download 16 years of monthly data.
Sol Waksman is an experienced media source, providing perspectives on hedge fund and managed futures trends. For more commentary or background, call 641-472-3456 or email firstname.lastname@example.org.
BarclayHedge was founded in 1985 and actively tracks more than 6,200 hedge funds, funds of hedge funds, and managed futures programs. Each month Barclay provides updated performance rankings for 38 Hedge Fund categories, 16 CTA categories, and 7 UCITS categories.
Institutional investors, brokerage firms, and private banks worldwide utilize BarclayHedge indices as performance benchmarks for the hedge fund and managed futures industries.